Cushman & Wakefield Ltd.
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2025-09-30; filed 2025-10-30.
0001628369-25-000060
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresCurrent report: 10-Q
Period ended 2026-03-31; filed 2026-05-07.
0001628369-26-000060
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 15 previous paragraphs and 4 current paragraphs.
3 unchanged; 1 reworded; 0 added; 11 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
The current filing states there were no material changes to risk factors.
This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.
Current filing’s statement
There have been no material changes to our risk factors as previously disclosed in our 2025 Annual Report.
Removed paragraphs (11)
Previous report
There is no guarantee the Redomiciliation will be completed or, if completed, will result in the anticipated benefits to the Company and its shareholders.
Previous report
Completion of the Redomiciliation is subject to satisfaction of multiple conditions, including approval of an applicable court under the laws of England and Wales. We obtained shareholder approval to effect the Redomiciliation at a series of back-to-back shareholder meetings held on October 16, 2025. However, completion of the Redomiciliation remains subject to other conditions and there can be no assurance that the Company will obtain the necessary U.K. court approvals to proceed with the Redomiciliation, and further, our Board of Directors reserves the right to elect to abandon the Redomiciliation at any time. If the Redomiciliation is not completed for any reason, we may experience negative reactions from the financial markets, which in turn could have a negative impact on our share price. Additionally, a further delay in completing the Redomiciliation could divert management attention or cause the Company to lose some or all of the anticipated benefits of the Redomiciliation. Even if the Redomiciliation is completed, there can be no assurance that we will achieve all of the anticipated benefits, or any of them.
Previous report
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Previous report
Item 3. Defaults Upon Senior Securities
Previous report
Disclosure Channels to Disseminate Information
Previous report
Cushman & Wakefield investors and others should note that we announce material information to the public about the Company through a variety of means, including the Company’s website, press releases and SEC filings, in order to achieve broad, non-exclusionary distribution of information to the public. We encourage investors and others to review the information we make public, as such information could be deemed to include material information about the Company.
Previous report
During the fiscal quarter ended September 30, 2025, none of our directors or officers subject to Section 16 of the Exchange Actadopted orterminated any contract, instruction or written plan for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act and/or any “non-Rule 10b5-1 trading arrangement” (as defined in Item 408(c) of Regulation S-K).
Reworded paragraphs (1)
Previous wording
Other than the additional risk factor below, there have been no material changes to our risk factors as previously disclosed in our 2024 Annual Report.
Current wording
There have been no material changes to our risk factors as previously disclosed in our 2025 Annual Report.